Jill Ann Howe
CIK 1892397 · Chief Financial Officer · last filed 2026-03-06
Jill Ann Howe is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for LCTX, was dated Mar 6, 2026. Across all open-market trades the lifetime net is +$18.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $32.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$32.4K
3
12
$18.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | Chief Financial Officer | 25,500 | $1.27 | $32.4K | $18.2K | 7 | 2026-03-06 |
| BIORA THERAPEUTICS, INC. (BIOR) Delisted | Director | 31,916 | $0.22 | $7.0K | $0 | 4 | 2024-06-06 |
| BIORA THERAPEUTICS, INC. (PROG) Delisted | Director | 76,754 | $0.88 | $67.9K | $0 | 1 | 2021-11-05 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-06 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2025-03-12 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2024-11-26 | LCTX | Buy (P) | +15,000 | $8.8K | EDGAR |
| 2024-08-19 | LCTX | Buy (P) | +10,500 | $9.3K | EDGAR |
| 2024-06-06 | BIORA THERAPEUTICS, INC. (BIOR) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-03-08 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | BIORA THERAPEUTICS, INC. (BIOR) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2023-03-10 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | BIORA THERAPEUTICS, INC. (BIOR) Delisted | Disp (D) | −19 | $0 | EDGAR |
| 2022-11-16 | LCTX | Grant (A) | — | $0 | EDGAR |